Welcome to the ASCEND study
ASCEND is a clinical trial of a drug called depemokimab, which aims to reduce the number of asthma exacerbations experienced by people with moderate to severe asthma over the autumn and winter time.
ASCEND Study News
- ASCEND Drop-in SessionsPre-Screening Support Available Our ASCEND Clinical Fellow, Dr Margaret Gleeson, is sharing her experience of pre-screening for the study at the following Teams sessions: If you would like to learn more or have any questions,… Read more: <b>ASCEND Drop-in Sessions</b>
- Welcome to the ASCEND Website!This is your one stop shop for regular recruitment updates, study FAQs and access to key study documents. Please check in regularly for more news as we move closer to the recruitment deadline for the… Read more: <b>Welcome to the ASCEND Website!</b>
The ASCEND study is open to recruitment until the end of October 2025.
Recruitment total:
176
Target: 170
🎉 Target met!
8 Trial Sites and 10 Participant Identification Centres (PICs)
